Insider · CIK 1193210
Bruce C Cozadd
- Director at Jazz Pharmaceuticals JAZZ: 1 buys, 179 sales
- Director at Cerus CERS: 0 buys, 3 sales
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys1
Open-market sales182
Bought$86K
Sold$98.6M
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Nov 2, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $215.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 2, 2026. | $1.3M | 339,875 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Nov 2, 2026. |
| Oct 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $230.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. | $1.4M | 345,875 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. |
| Sep 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $250.13 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. | $1.5M | 351,875 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. |
| Aug 31, 2026 | Jazz Pharmaceuticals JAZZ | Tax withholding 10 sh at $244.06 The same day as a Form 144 notice of a planned insider sale filed Aug 31, 2026. | $2K | 359,084 | The same day as a Form 144 notice of a planned insider sale filed Aug 31, 2026. |
| Aug 31, 2026 | Jazz Pharmaceuticals JAZZ | Tax withholding 1,209 sh at $241.39 The same day as a Form 144 notice of a planned insider sale filed Aug 31, 2026. | $292K | 357,875 | The same day as a Form 144 notice of a planned insider sale filed Aug 31, 2026. |
| Aug 5, 2026 | Jazz Pharmaceuticals JAZZ | Award 1,605 sh 2 days after the company's 8-K filed Aug 3, 2026. | 362,287 | 2 days after the company's 8-K filed Aug 3, 2026. | |
| Aug 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $252.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Aug 3, 2026. | $1.5M | 360,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as the company's 8-K filed Aug 3, 2026. |
| Jul 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $240.47 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. | $1.4M | 366,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. |
| Jun 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $235.12 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. | $1.4M | 372,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. |
| May 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $203.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 1, 2026. | $1.2M | 378,682 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 1, 2026. |
| Apr 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,684 sh at $190.22 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. | $701K | 386,998 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. |
| Apr 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,292 sh at $190.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. | $438K | 384,706 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. |
| Apr 1, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 24 sh at $191.74 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. | $5K | 384,682 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Apr 1, 2026. |
| Mar 5, 2026 | Jazz Pharmaceuticals JAZZ | Tax withholding 15,114 sh at $188.69 The same day as a Form 144 notice of a planned insider sale filed Mar 5, 2026. | $2.9M | 390,682 | The same day as a Form 144 notice of a planned insider sale filed Mar 5, 2026. |
| Mar 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,159 sh at $186.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. | $588K | 408,637 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. |
| Mar 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,608 sh at $186.73 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. | $487K | 406,029 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. |
| Mar 3, 2026 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 233 sh at $187.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. | $44K | 405,796 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Mar 3, 2026. |
| Jan 16, 2026 | Jazz Pharmaceuticals JAZZ | Award 35,917 sh 4 days after the company's 8-K filed Jan 12, 2026. | 429,249 | 4 days after the company's 8-K filed Jan 12, 2026. | |
| Jan 16, 2026 | Jazz Pharmaceuticals JAZZ | Tax withholding 17,453 sh at $171.16 4 days after the company's 8-K filed Jan 12, 2026. | $3M | 411,796 | 4 days after the company's 8-K filed Jan 12, 2026. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Option exercise 76,689 sh at $123.36 The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $9.5M | 470,021 | The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Option exercise 811 sh at $123.36 The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $100K | 470,832 | The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 30,487 sh at $178.06 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $5.4M | 440,345 −6% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 8,380 sh at $179.23 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $1.5M | 431,965 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 507 sh at $179.79 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $91K | 431,458 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 26, 2025 | Jazz Pharmaceuticals JAZZ | Sold 38,126 sh at $177.27 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. | $6.8M | 393,332 −9% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 26, 2025. |
| Nov 20, 2025 | Jazz Pharmaceuticals JAZZ | Award 2,506 sh The same day as a Form 144 notice of a planned insider sale filed Nov 20, 2025. | 393,332 | The same day as a Form 144 notice of a planned insider sale filed Nov 20, 2025. | |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 3,384 sh at $180.09 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $609K | 405,442 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 8,382 sh at $180.88 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $1.5M | 397,060 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 5,517 sh at $181.81 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $1M | 391,543 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Nov 18, 2025 | Jazz Pharmaceuticals JAZZ | Sold 717 sh at $182.60 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. | $131K | 390,826 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 18, 2025. |
| Oct 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,500 sh at $140.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 3, 2025. | $490K | 408,826 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 3, 2025. |
| Oct 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $131.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 54 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. | $264K | 412,326 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 54 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. |
| Sep 14, 2025 | Jazz Pharmaceuticals JAZZ | Tax withholding 15,647 sh at $126.16 37 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. | $2M | 414,326 | 37 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. |
| Sep 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $127.23 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. | $382K | 432,973 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. |
| Sep 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. | $390K | 429,973 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 25 days after a Form 144 notice of a planned insider sale filed Aug 8, 2025. |
| Aug 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $113.21 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. | $113K | 435,973 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 1, 2025. |
| Jul 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $105.26 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. | $53K | 437,473 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. |
| Jul 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $110.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. | $55K | 436,973 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2025. |
| Jun 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $110.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Jun 2, 2025. | $55K | 437,973 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed Jun 2, 2025. |
| Jun 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $107.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 2, 2025. | $54K | 438,473 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 2, 2025. |
| May 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $120.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed May 1, 2025. | $60K | 438,807 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 1 day after a Form 144 notice of a planned insider sale filed May 1, 2025. |
| May 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $116.35 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 1, 2025. | $116K | 439,307 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed May 1, 2025. |
| Apr 1, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $123.75 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 27 days after the company's 8-K/A filed Mar 5, 2025. | $186K | 440,307 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 27 days after the company's 8-K/A filed Mar 5, 2025. |
| Mar 5, 2025 | Jazz Pharmaceuticals JAZZ | Returned to company 22,251 sh at $138.95 The same day as the company's 8-K/A filed Mar 5, 2025. | $3.1M | 441,807 | The same day as the company's 8-K/A filed Mar 5, 2025. |
| Mar 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,500 sh at $144.25 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 10-K filed Feb 26, 2025. | $938K | 464,058 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 5 days after the company's 10-K filed Feb 26, 2025. |
| Feb 27, 2025 | Jazz Pharmaceuticals JAZZ | Award 30,814 sh 1 day after the company's 10-K filed Feb 26, 2025. | 470,558 | 1 day after the company's 10-K filed Feb 26, 2025. | |
| Feb 3, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $122.31 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 21 days after the company's 8-K filed Jan 13, 2025. | $183K | 439,744 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 21 days after the company's 8-K filed Jan 13, 2025. |
| Jan 17, 2025 | Jazz Pharmaceuticals JAZZ | Award 29,559 sh 4 days after the company's 8-K filed Jan 13, 2025. | 455,084 | 4 days after the company's 8-K filed Jan 13, 2025. | |
| Jan 17, 2025 | Jazz Pharmaceuticals JAZZ | Tax withholding 13,840 sh at $122.62 4 days after the company's 8-K filed Jan 13, 2025. | $1.7M | 441,244 | 4 days after the company's 8-K filed Jan 13, 2025. |
| Jan 2, 2025 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $123.43 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 37 days after the company's 8-K filed Nov 26, 2024. | $185K | 425,525 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 37 days after the company's 8-K filed Nov 26, 2024. |
| Dec 2, 2024 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $121.17 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Nov 26, 2024. | $242K | 427,025 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 6 days after the company's 8-K filed Nov 26, 2024. |
| Nov 1, 2024 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $110.84 The filing says this sale was under a Rule 10b5-1 plan set up in advance. 56 days after the company's 8-K filed Sep 6, 2024. | $111K | 428,976 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. 56 days after the company's 8-K filed Sep 6, 2024. |
| Mar 5, 2024 | Jazz Pharmaceuticals JAZZ | Tax withholding 22,436 sh at $117.53 7 days after the company's 8-K filed Feb 27, 2024. | $2.6M | 429,809 | 7 days after the company's 8-K filed Feb 27, 2024. |
| Mar 1, 2024 | Jazz Pharmaceuticals JAZZ | Award 50,187 sh 3 days after the company's 8-K filed Feb 27, 2024. | 452,245 | 3 days after the company's 8-K filed Feb 27, 2024. | |
| Jan 17, 2024 | Jazz Pharmaceuticals JAZZ | Award 26,545 sh 9 days after the company's 8-K filed Jan 8, 2024. | 414,303 | 9 days after the company's 8-K filed Jan 8, 2024. | |
| Jan 17, 2024 | Jazz Pharmaceuticals JAZZ | Tax withholding 12,245 sh at $119.13 9 days after the company's 8-K filed Jan 8, 2024. | $1.5M | 402,058 | 9 days after the company's 8-K filed Jan 8, 2024. |
| Mar 5, 2023 | Jazz Pharmaceuticals JAZZ | Tax withholding 21,882 sh at $142.78 | $3.1M | 387,584 | |
| Mar 3, 2023 | Jazz Pharmaceuticals JAZZ | Award 42,388 sh | 409,466 | ||
| Feb 1, 2023 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $155.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $156K | 367,078 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 3, 2023 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $159.59 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $160K | 370,078 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 3, 2023 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $320K | 368,078 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $157.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $157K | 371,078 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 10, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $300K | 372,028 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 3, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 62,905 sh at $59.13 | $3.7M | 419,213 | |
| Oct 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 13,791 sh at $134.02 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.8M | 405,422 −3% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Oct 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 23,646 sh at $135.18 The filing does not mark this sale as under a Rule 10b5-1 plan. | $3.2M | 381,776 −6% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Oct 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 7,748 sh at $135.80 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.1M | 374,028 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $155.10 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $155K | 353,311 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $59.13 | $574K | 363,011 | |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 4,517 sh at $152.41 The filing does not mark this sale as under a Rule 10b5-1 plan. | $688K | 358,494 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,170 sh at $153.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $179K | 357,324 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 474 sh at $154.31 The filing does not mark this sale as under a Rule 10b5-1 plan. | $73K | 356,850 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Sep 6, 2022 | Jazz Pharmaceuticals JAZZ | Sold 542 sh at $155.22 The filing does not mark this sale as under a Rule 10b5-1 plan. | $84K | 356,308 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,632 sh at $46.83 | $451K | 361,544 | |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 68 sh at $59.13 | $4K | 361,612 | |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,600 sh at $153.48 The filing does not mark this sale as under a Rule 10b5-1 plan. | $399K | 359,012 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,601 sh at $154.50 The filing does not mark this sale as under a Rule 10b5-1 plan. | $402K | 356,411 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,100 sh at $155.27 The filing does not mark this sale as under a Rule 10b5-1 plan. | $171K | 355,311 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $154.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $155K | 354,311 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 360,687 | |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold 5,839 sh at $156.65 The filing does not mark this sale as under a Rule 10b5-1 plan. | $915K | 354,848 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold 436 sh at $157.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $69K | 354,412 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $156.95 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $157K | 353,412 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 5, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $240K | 351,912 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 350,987 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 358,349 | |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,412 sh at $145.42 The filing does not mark this sale as under a Rule 10b5-1 plan. | $351K | 355,937 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,360 sh at $146.05 The filing does not mark this sale as under a Rule 10b5-1 plan. | $199K | 354,577 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,270 sh at $148.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $188K | 353,307 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 831 sh at $148.82 The filing does not mark this sale as under a Rule 10b5-1 plan. | $124K | 352,476 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jun 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 489 sh at $149.68 The filing does not mark this sale as under a Rule 10b5-1 plan. | $73K | 351,987 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 355,762 | |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,600 sh at $155.34 The filing does not mark this sale as under a Rule 10b5-1 plan. | $249K | 354,162 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,177 sh at $156.13 The filing does not mark this sale as under a Rule 10b5-1 plan. | $496K | 350,985 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 767 sh at $156.97 The filing does not mark this sale as under a Rule 10b5-1 plan. | $120K | 350,218 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold 716 sh at $158.53 The filing does not mark this sale as under a Rule 10b5-1 plan. | $114K | 349,502 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $158.67 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $159K | 348,502 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 356,834 | |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,750 sh at $156.33 The filing does not mark this sale as under a Rule 10b5-1 plan. | $274K | 355,084 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,228 sh at $157.49 The filing does not mark this sale as under a Rule 10b5-1 plan. | $508K | 351,856 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,294 sh at $158.37 The filing does not mark this sale as under a Rule 10b5-1 plan. | $205K | 350,562 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $158.64 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $159K | 349,562 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 4, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,500 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $560K | 346,062 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 17, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 1,288 sh at $59.13 | $76K | 347,134 | |
| Mar 5, 2022 | Jazz Pharmaceuticals JAZZ | Tax withholding 21,929 sh at $153.96 | $3.4M | 345,846 | |
| Mar 3, 2022 | Jazz Pharmaceuticals JAZZ | Award 44,788 sh | 367,775 | ||
| Mar 2, 2022 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 6,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $900K | 322,987 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 1, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 335,488 | |
| Mar 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,260 sh at $135.73 The filing does not mark this sale as under a Rule 10b5-1 plan. | $442K | 332,228 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Mar 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 3,041 sh at $136.73 The filing does not mark this sale as under a Rule 10b5-1 plan. | $416K | 329,187 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Mar 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 200 sh at $137.40 The filing does not mark this sale as under a Rule 10b5-1 plan. | $27K | 328,987 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 1, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 332,160 | |
| Feb 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,050 sh at $138.11 The filing does not mark this sale as under a Rule 10b5-1 plan. | $283K | 330,110 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,136 sh at $139.24 The filing does not mark this sale as under a Rule 10b5-1 plan. | $297K | 327,974 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 1, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,186 sh at $140.26 The filing does not mark this sale as under a Rule 10b5-1 plan. | $307K | 325,788 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 328,251 | |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,819 sh at $126.72 The filing does not mark this sale as under a Rule 10b5-1 plan. | $231K | 326,432 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 1,181 sh at $127.58 The filing does not mark this sale as under a Rule 10b5-1 plan. | $151K | 325,251 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 2,651 sh at $128.67 The filing does not mark this sale as under a Rule 10b5-1 plan. | $341K | 322,600 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 3, 2022 | Jazz Pharmaceuticals JAZZ | Sold 140 sh at $129.34 The filing does not mark this sale as under a Rule 10b5-1 plan. | $18K | 322,460 −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Dec 1, 2021 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 325,299 | |
| Dec 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 3,990 sh at $122.38 The filing does not mark this sale as under a Rule 10b5-1 plan. | $488K | 321,309 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Dec 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 2,758 sh at $123.06 The filing does not mark this sale as under a Rule 10b5-1 plan. | $339K | 318,551 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 1, 2021 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 322,092 | |
| Nov 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 1,893 sh at $133.70 The filing does not mark this sale as under a Rule 10b5-1 plan. | $253K | 320,199 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 1,934 sh at $134.78 The filing does not mark this sale as under a Rule 10b5-1 plan. | $261K | 318,265 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold 2,729 sh at $135.45 The filing does not mark this sale as under a Rule 10b5-1 plan. | $370K | 315,536 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Oct 4, 2021 | Jazz Pharmaceuticals JAZZ | Option exercise 9,700 sh at $46.83 | $454K | 318,990 | |
| Oct 4, 2021 | Jazz Pharmaceuticals JAZZ | Sold 6,598 sh at $129.87 The filing does not mark this sale as under a Rule 10b5-1 plan. | $857K | 312,392 −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 5, 2021 | Jazz Pharmaceuticals JAZZ | Option exercise 2,652 sh at $46.83 | $124K | 309,790 | |
| Aug 2, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $169.98 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $255K | 307,388 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 2, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $43K | 307,138 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 10,850 sh at $180.67 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $2M | 308,888 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,750 sh at $179.07 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $313K | 319,738 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 5, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $85K | 321,341 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 3, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $164.24 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $246K | 321,841 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,500 sh at $164.96 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $247K | 323,341 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 5, 2021 | Jazz Pharmaceuticals JAZZ | Tax withholding 21,516 sh at $164.75 | $3.5M | 324,841 | |
| Mar 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 9,600 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $1.6M | 346,357 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 25, 2021 | Jazz Pharmaceuticals JAZZ | Award 37,925 sh | 355,957 | ||
| Feb 3, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $160.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $40K | 318,032 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 1, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,250 sh at $156.15 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $195K | 318,282 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 4, 2021 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 7,950 sh at $162.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $1.3M | 319,532 −2% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 3, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $38K | 327,482 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 1, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $140.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $141K | 327,732 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 3, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $154.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $385K | 328,680 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 2, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $145.13 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $145K | 331,180 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 1, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,500 sh at $141.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $639K | 332,180 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 1, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $134.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $67K | 336,680 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 27, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $390K | 337,180 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 5, 2020 | Jazz Pharmaceuticals JAZZ | Tax withholding 15,071 sh at $124.50 | $1.9M | 340,033 | |
| Feb 27, 2020 | Jazz Pharmaceuticals JAZZ | Award 52,000 sh | 355,104 | ||
| Feb 25, 2020 | Jazz Pharmaceuticals JAZZ | Tax withholding 2,679 sh at $127.25 | $341K | 303,104 | |
| Feb 24, 2020 | Jazz Pharmaceuticals JAZZ | Option exercise 6,895 sh at $11.48 | $79K | 305,783 | |
| Feb 3, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $143.83 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $144K | 298,888 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 2, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $149.51 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 300,138 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 2, 2020 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 250 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $38K | 299,888 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 2, 2019 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 10,750 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $1.6M | 301,138 −3% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 5, 2019 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $65K | 311,855 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 1, 2019 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 500 sh at $130.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $65K | 312,355 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 5, 2019 | Jazz Pharmaceuticals JAZZ | Tax withholding 4,586 sh at $135.82 | $623K | 317,003 | |
| Mar 5, 2019 | Jazz Pharmaceuticals JAZZ | Tax withholding 4,288 sh at $135.82 | $582K | 312,715 | |
| Feb 28, 2019 | Jazz Pharmaceuticals JAZZ | Award 50,000 sh | 321,589 | ||
| Feb 26, 2019 | Jazz Pharmaceuticals JAZZ | Tax withholding 3,420 sh at $127.76 | $437K | 271,589 | |
| Feb 25, 2019 | Jazz Pharmaceuticals JAZZ | Tax withholding 2,679 sh at $126.25 | $338K | 275,009 | |
| Dec 3, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $151.78 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $152K | 277,688 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,300 sh at $159.45 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $207K | 278,615 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,300 sh at $167.99 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $218K | 279,915 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 21, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,300 sh at $164.36 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $214K | 281,215 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,600 sh at $173.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $278K | 282,515 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jul 2, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,600 sh at $170.81 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $273K | 284,115 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $170.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $510K | 289,715 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $168.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $672K | 285,715 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 1, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $151.57 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $152K | 292,542 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 2, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 293,542 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 9, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 294,542 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 5, 2018 | Jazz Pharmaceuticals JAZZ | Tax withholding 4,288 sh at $143.39 | $615K | 295,542 | |
| Mar 1, 2018 | Jazz Pharmaceuticals JAZZ | Award 37,000 sh | 299,830 | ||
| Feb 28, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 262,830 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 27, 2018 | Jazz Pharmaceuticals JAZZ | Tax withholding 3,638 sh at $143.80 | $523K | 263,830 | |
| Feb 26, 2018 | Jazz Pharmaceuticals JAZZ | Tax withholding 6,269 sh at $147.44 | $924K | 267,468 | |
| Jan 12, 2018 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 3,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $450K | 273,737 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 2, 2017 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 276,664 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 12, 2017 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $153.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $154K | 277,664 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 6, 2017 | Cerus CERS | Option exercise 10,133 sh | 18,921 | ||
| May 11, 2017 | Jazz Pharmaceuticals JAZZ | Sold 12,073 sh at $153.17 The filing does not mark this sale as under a Rule 10b5-1 plan. | $1.8M | 296,418 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| May 11, 2017 | Jazz Pharmaceuticals JAZZ | Sold 17,927 sh at $153.68 The filing does not mark this sale as under a Rule 10b5-1 plan. | $2.8M | 278,491 −6% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Apr 11, 2017 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $152.12 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $152K | 308,491 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 6, 2017 | Jazz Pharmaceuticals JAZZ | Tax withholding 5,000 sh at $132.81 | $664K | 309,491 | |
| Mar 2, 2017 | Jazz Pharmaceuticals JAZZ | Award 34,600 sh | 314,491 | ||
| Feb 27, 2017 | Jazz Pharmaceuticals JAZZ | Tax withholding 10,272 sh at $136.97 | $1.4M | 279,891 | |
| Aug 9, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $150.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $150K | 299,184 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 9, 2016 | Jazz Pharmaceuticals JAZZ | Tax withholding 9,071 sh at $150.01 | $1.4M | 290,113 | |
| Mar 8, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $126.04 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $315K | 300,066 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 7, 2016 | Jazz Pharmaceuticals JAZZ | Tax withholding 4,493 sh at $127.84 | $574K | 302,566 | |
| Feb 29, 2016 | Jazz Pharmaceuticals JAZZ | Tax withholding 3,230 sh at $121.58 | $393K | 307,059 | |
| Feb 26, 2016 | Jazz Pharmaceuticals JAZZ | Tax withholding 2,607 sh at $125.00 | $326K | 310,289 | |
| Feb 25, 2016 | Jazz Pharmaceuticals JAZZ | Award 31,000 sh | 312,896 | ||
| Feb 9, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $111.37 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $278K | 281,896 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 12, 2016 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $123.81 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $310K | 284,396 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 8, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $139.72 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $349K | 286,855 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 10, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $128.53 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $321K | 289,355 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 13, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $131.50 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $329K | 291,855 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 8, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,040 sh at $162.86 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $332K | 294,815 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 8, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 460 sh at $164.01 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $75K | 294,355 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 11, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 2,500 sh at $177.82 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $445K | 296,855 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 10, 2015 | Jazz Pharmaceuticals JAZZ | Tax withholding 7,743 sh at $181.48 | $1.4M | 299,355 | |
| Jul 14, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $177.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $889K | 542,224 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 9, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $173.16 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $866K | 547,224 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 12, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $173.85 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $869K | 551,967 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 24, 2015 | Cerus CERS | Option exercise 3,333 sh at $3.66 | $12K | 8,788 | |
| Apr 14, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $181.45 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $907K | 556,967 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 10, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $170.35 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $852K | 561,967 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 5, 2015 | Jazz Pharmaceuticals JAZZ | Tax withholding 6,522 sh at $174.76 | $1.1M | 566,967 | |
| Feb 27, 2015 | Jazz Pharmaceuticals JAZZ | Tax withholding 3,442 sh at $170.09 | $585K | 573,489 | |
| Feb 26, 2015 | Jazz Pharmaceuticals JAZZ | Award 27,800 sh | 576,931 | ||
| Feb 10, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $166.90 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $835K | 549,131 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 13, 2015 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $161.73 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $809K | 554,131 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 9, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $178.79 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $894K | 559,131 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 8, 2014 | Cerus CERS | Option exercise 3,334 sh at $2.95 | $10K | 7,932 | |
| Dec 8, 2014 | Cerus CERS | Tax withholding 2,282 sh at $4.31 | $10K | 5,650 | |
| Dec 8, 2014 | Cerus CERS | Sold 195 sh at $4.31 The filing does not mark this sale as under a Rule 10b5-1 plan. | $840 | 5,455 −3% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Nov 11, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $173.63 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $868K | 564,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 14, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $142.77 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $714K | 569,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 9, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $170.32 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $852K | 574,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 14, 2014 | Cerus CERS | Option exercise 3,333 sh at $2.14 | $7K | 7,242 | |
| Aug 14, 2014 | Cerus CERS | Tax withholding 1,986 sh at $3.59 | $7K | 5,256 | |
| Aug 14, 2014 | Cerus CERS | Sold 658 sh at $3.59 The filing does not mark this sale as under a Rule 10b5-1 plan. | $2K | 4,598 −13% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Aug 12, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $133.15 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $666K | 579,023 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 11, 2014 | Jazz Pharmaceuticals JAZZ | Tax withholding 13,044 sh at $133.86 | $1.7M | 584,023 | |
| Jul 8, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $155.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $775K | 597,067 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 10, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $142.34 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $712K | 602,067 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 13, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $128.92 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $645K | 606,810 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 8, 2014 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $123.18 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $616K | 611,810 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 2, 2014 | Cerus CERS | Option exercise 3,333 sh at $3.25 | $11K | 6,667 | |
| Apr 2, 2014 | Cerus CERS | Tax withholding 2,202 sh at $4.92 | $11K | 4,465 | |
| Apr 2, 2014 | Cerus CERS | Sold 556 sh at $4.92 The filing does not mark this sale as under a Rule 10b5-1 plan. | $3K | 3,909 −12% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Mar 5, 2014 | Jazz Pharmaceuticals JAZZ | Tax withholding 6,522 sh at $157.60 | $1M | 616,810 | |
| Feb 27, 2014 | Jazz Pharmaceuticals JAZZ | Sold 25,000 sh at $158.36 The filing does not mark this sale as under a Rule 10b5-1 plan. | $4M | 600,754 −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Feb 27, 2014 | Jazz Pharmaceuticals JAZZ | Gift 10,422 sh | 590,332 | ||
| Feb 27, 2014 | Jazz Pharmaceuticals JAZZ | Award 33,000 sh | 623,332 | ||
| Nov 11, 2013 | Cerus CERS | Option exercise 3,334 sh at $4.54 | $15K | 3,334 | |
| Oct 8, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $88.58 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $354K | 625,647 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Sep 10, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $87.59 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $438K | 629,647 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 13, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $81.86 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $409K | 634,647 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 9, 2013 | Jazz Pharmaceuticals JAZZ | Tax withholding 13,044 sh at $80.88 | $1.1M | 639,647 | |
| Jul 9, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $73.30 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $367K | 652,691 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 11, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 5,000 sh at $68.33 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $342K | 657,691 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jun 3, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 1,452 sh at $11.48 | $17K | 662,691 | |
| May 21, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 660,643 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 14, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $58.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $234K | 661,643 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| May 3, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 665,643 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Apr 9, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $54.52 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $218K | 666,643 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 21, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 15,902 sh at $15.09 | $240K | 638,063 | |
| Mar 21, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 5,299 sh at $30.18 | $160K | 643,362 | |
| Mar 21, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 5,299 sh at $45.27 | $240K | 648,661 | |
| Mar 21, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 12,583 sh at $19.37 | $244K | 661,244 | |
| Mar 21, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 7,040 sh at $7.96 | $56K | 668,284 | |
| Mar 21, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 182 sh at $1.25 | $228 | 668,466 | |
| Mar 21, 2013 | Jazz Pharmaceuticals JAZZ | Option exercise 2,177 sh at $11.48 | $25K | 670,643 | |
| Mar 12, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $59.48 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $238K | 623,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 12, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 622,161 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Mar 5, 2013 | Jazz Pharmaceuticals JAZZ | Award 50,000 sh | 627,161 | ||
| Mar 4, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 1,000 sh at $60.00 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $60K | 577,161 −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Feb 12, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $56.23 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $225K | 578,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Jan 8, 2013 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $55.60 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $222K | 582,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Dec 11, 2012 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $50.55 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $202K | 586,161 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Nov 13, 2012 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $51.11 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $204K | 589,662 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Oct 9, 2012 | Jazz Pharmaceuticals JAZZ | Sold (10b5-1) 4,000 sh at $56.69 The filing says this sale was under a Rule 10b5-1 plan set up in advance. | $227K | 593,662 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. |
| Aug 9, 2012 | Jazz Pharmaceuticals JAZZ | Award 100,000 sh | 597,662 | ||
| May 31, 2012 | Jazz Pharmaceuticals JAZZ | Other 596 sh at $25.13 | $15K | 497,662 | |
| Mar 9, 2012 | Jazz Pharmaceuticals JAZZ | Sold 50,000 sh at $49.56 The filing does not mark this sale as under a Rule 10b5-1 plan. | $2.5M | 497,066 −9% | The filing does not mark this sale as under a Rule 10b5-1 plan. |
| Jan 30, 2012 | Jazz Pharmaceuticals JAZZ | Other 255 sh | 547,066 | ||
| Jan 18, 2012 | Jazz Pharmaceuticals JAZZ | Award 546,811 sh at $47.34 | $25.9M | 546,811 | |
| Jan 18, 2012 | Jazz Pharmaceuticals JAZZ | Returned to company 546,811 sh at $47.34 | $25.9M | 0 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 148,218 sh at $15.09 | $2.2M | 437,229 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 93,725 sh at $48.60 | $4.6M | 343,504 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 49,408 sh at $30.18 | $1.5M | 392,912 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 39,422 sh at $48.60 | $1.9M | 353,490 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 49,408 sh at $45.27 | $2.2M | 402,898 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 47,602 sh at $48.60 | $2.3M | 355,296 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 28,079 sh at $19.37 | $544K | 383,375 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 17,477 sh at $48.60 | $849K | 365,898 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 99,460 sh at $7.96 | $792K | 465,358 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 54,744 sh at $48.60 | $2.7M | 410,614 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 199,818 sh at $1.25 | $250K | 610,432 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 96,014 sh at $48.60 | $4.7M | 514,418 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 122,580 sh at $11.48 | $1.4M | 636,998 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 72,659 sh at $48.60 | $3.5M | 564,339 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Option exercise 140,000 sh at $27.46 | $3.8M | 704,339 | |
| Jan 11, 2012 | Jazz Pharmaceuticals JAZZ | Tax withholding 107,528 sh at $48.60 | $5.2M | 596,811 | |
| Nov 30, 2011 | Jazz Pharmaceuticals JAZZ | Other 596 sh at $25.13 | $15K | 289,011 | |
| Nov 16, 2011 | Jazz Pharmaceuticals JAZZ | Gift 50,000 sh | 546,811 | ||
| May 31, 2011 | Jazz Pharmaceuticals JAZZ | Other 3,640 sh | 288,415 | ||
| Nov 30, 2010 | Jazz Pharmaceuticals JAZZ | Other 4,594 sh | 284,775 | ||
| Aug 31, 2010 | Jazz Pharmaceuticals JAZZ | Bought 10,000 sh at $8.60 Their first open-market buy here in SEC Tracker's records. | $86K | 280,181 +4% | Their first open-market buy here in SEC Tracker's records. |
| May 28, 2010 | Jazz Pharmaceuticals JAZZ | Other 3,843 sh | 270,181 | ||
| Nov 30, 2009 | Jazz Pharmaceuticals JAZZ | Other 5,846 sh | 266,338 | ||
| May 29, 2009 | Jazz Pharmaceuticals JAZZ | Other 5,125 sh | 260,492 | ||
| Nov 28, 2008 | Jazz Pharmaceuticals JAZZ | Other 379 sh at $1.28 | $485 | 255,367 | |
| May 30, 2008 | Jazz Pharmaceuticals JAZZ | Other 1,203 sh at $6.50 | $8K | 254,988 | |
| May 16, 2008 | Jazz Pharmaceuticals JAZZ | Award 7,223 sh | 253,785 | ||
| Nov 30, 2007 | Jazz Pharmaceuticals JAZZ | Other 1,388 sh at $13.18 | $18K | 246,562 | |
| Jun 6, 2007 | Jazz Pharmaceuticals JAZZ | Conversion 66,264 sh | 245,174 |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.
Data on this page was fetched . The filing on SEC.gov is the record.